Medifast, Inc.

MED · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$2$99$144$164
Dep. & Amort.$17$13$11$7
Deferred Tax-$7$1-$1-$4
Stock-Based Comp.$7$8$11$10
Change in WC-$10$20$22-$88
Other Non-Cash$15$5$8$5
Operating Cash Flow$24$148$195$95
Investing Activities
PP&E Inv.-$7-$6-$17-$34
Net Acquisitions$0$0$0$0
Inv. Purchases-$47-$55$0$0
Inv. Sales/Matur.$27$0$5$5
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$27-$61-$11-$29
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$1-$7-$128-$62
Dividends Paid-$1-$73-$72-$64
Other Fin. Act.$0$0$0$1
Financing Cash Flow-$2-$80-$200-$125
Forex Effect$0-$0-$0$0
Net Chg. in Cash-$4$7-$16-$60
Supplemental Information
Beg. Cash$94$88$104$164
End Cash$91$94$88$104
Free Cash Flow$17$141$178$60
Medifast, Inc. (MED) Financial Statements & Key Stats | AlphaPilot